ZOMETAŽ Official Site | Virtual Exhibit Booth
Home


About ZOMETA

ZOMETA Patient Case Studies

Zometa Dosing & Administration

ZOMETA Safety & Tolerability

ZOMETA Clinical News
Recent Publications
Key Clinical Trial Publications
Zometa Virtual Exhibit Booth

ZOMETA For Your Patients

Professional Resource Center

ZOMETA Around the World
Videos
View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

 
European Summary of Product Characteristics
For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics
 
Virtual Exhibit Booth ZOMETA Virtual Exhibit Booth
 

ZOMETA Virtual Exhibit Booth


ZOMETA virtual booth interactively matches your experience to that of attendees at International Scientific Congresses such as European Cancer Organisation (ECCO)

Move your mouse below for more information
1. Threat of Skeletal Related Events 4. Dose ZOMETA Every 3-4 Weeks
2. ZOMETA Mechanism of Action 5. Continue ZOMETA for up to 2 Years
3. ZOMETA Efficacy 6. ZOMETA is Generally Well Tolerated